Purchase Order 75N94020P00094

This is a firm fixed price service contract awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency within the National Institutes of Health (NIH), to Illumina, Inc. for a Bronze Support Plan for a HiSeq 2500 sequencing instrument and a cBOT instrument. The total ceiling value of the contract is $34,456.50 and the period of performance is from June 23, 2019 through June 22, 2020. The contract was not set aside for any small business programs....

The National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a $223,892.08 firm fixed price purchase order to Illumina, Inc. for a service contract to maintain the operation of Illumina HiSeq 3000 and cBOT DNA sequencing instruments. This non-competitive, brand-name contract was awarded under simplified acquisition procedures, as Illumina is the sole manufacturer and authorized provider of maintenance services for these instruments. The...

This is a firm fixed price purchase order contract awarded by the National Institute of Environmental Health Sciences (NIEHS), part of the Department of Health and Human Services, to Illumina, Inc. for a NovaSeq 6000 Bronze Sequencing Laboratory Equipment Service Agreement. The contract is valued at $86,760.00 and has a period of performance from June 29, 2025 to June 28, 2026. The contract was awarded on a sole source basis, as Illumina is the only responsible source capable of providing...

This firm fixed-price contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the Department of Health and Human Services, to Illumina, Inc., a manufacturer of sequencing and genomic analysis instruments and reagents. The contract provides for the maintenance and support of two Illumina sequencing instruments - a cBot-Basic and a HiSeq2000-Basic - to be used by NIAID. The total ceiling value of the contract is $359,909.31, with a...

The Department of Health and Human Services National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases awarded a $201,059.24 firm fixed price purchase order to Illumina, Inc., a for-profit manufacturer of genomics analysis instruments and reagents, for an annual NextSeq 550 sequencing instrument service plan. The contract has a base year from April 30, 2022 to April 29, 2023 with four one-year option periods. Illumina is the sole authorized service provider...

This is a one-year, $48,209 firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Illumina, Inc. for a renewal service agreement on an Illumina NextSeq 2000 genomic sequencing instrument used for research, diagnostics, and developing personalized medicine. The award is a sole-source contract for comprehensive maintenance and support services, including full coverage for parts,...

The Department of Health and Human Services National Institutes of Health National Human Genome Research Institute awarded a $25,959 purchase order to Illumina, Inc. to provide a NEXTSEQ 2000 SERVICE AGREEMENT. The contract has a firm fixed price and period of performance from September 29, 2023 through September 28, 2024. The original solicitation sought a service contract for NEXTSEQ 2000 maintenance and support services. As the prime contractor, Illumina will deliver these services for the...

This is a firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a division of the Department of Health and Human Services, to Illumina, Inc. for a 1-year Silver Support Plan to provide maintenance and repair services for NIAID's NextSeq 2000 and MiSeq scientific sequencing instruments. The contract, valued at $62,297.28, covers full coverage for parts, labor, and travel, as well as reagent replacement, remote technical support,...

Illumina, Inc. was awarded a service contract renewal for Bronze Level maintenance support on an Illumina HiSeq 3000 sequencing instrument (Serial Number J00175) located in Stoneville, Mississippi. This $69.2K firm fixed-price call was issued under a Blanket Purchase Agreement (BPA) on August 21, 2018, with an ultimate completion date of September 20, 2019. The contract contains no set-aside designation, reflecting Illumina's specialized technological capabilities in genomic sequencing equipment...

This is a definitive contract awarded by the Food and Drug Administration (FDA) to Illumina, Inc., a manufacturer of sequencing and genomic analysis instruments and reagents. The contract, with a ceiling value of $478,120.70, is for preventive maintenance services for the HiSeq 2500, MiSeq, cBot, and iCompute systems used by the agency. The contract is a firm fixed-price arrangement with no set-aside designation. Illumina has previously provided sequencing systems and services under prime...